EDGAR Filing Documents for 0001095435-13-000085

Form 424B3 - Prospectus [Rule 424(b)(3)]:

SEC Accession No. 0001095435-13-000085

Filing Date

2013-12-23

Accepted

2013-12-23 12:58:54

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		prospsupp40.htm	424B3	54897
2	SPECIMEN OF COMMON STOCK	certspec2013.htm	EX-4.1	540
3	SPECIMEN OF COMMON STOCK	certspec2013.pdf	EX-4.1	619608
4	OPINION OF OLSHAN FROME WOLOSKY LLP	legalopinion2013.htm	EX-5.1	10831
5	2013 STOCK OPTION PLAN	stockcompensation2013.htm	EX-10	28548
6	CONSENT OF OLSHAN FROME WOLOSKY LLP (CONTAINED AS PART OF EXHIBIT 5.1).	legalconsent2013.htm	EX-23.1	10764
7	CONSENT OF SCHWARTZ LEVISKY FELDMAN LLP CHARTERED ACCOUNTANTS.	auditorconsent2013.htm	EX-23.2	7074
8	POWER OF ATTORNEY	powerofattorney2013.htm	EX-24	8518
	Complete submission text file	0001095435-13-000085.txt		976192

Mailing Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3

Business Address 47 AVENUE ROAD SUITE 200 TORONTO A6 M5R 2G3 416-929-1806

PORTAGE BIOTECH INC. (Filer) CIK: 0001095435 (see all company filings)